
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Revealing the Specialty of Food Matching: Improving Culinary Encounters - 2
From Educational Loans to Obligation Free: Independence from the rat race Accomplished - 3
French rapper Gims placed under investigation for 'aggravated money laundering' - 4
Electric Vehicles for Eco-Accommodating Driving - 5
Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico
At least 490 protesters killed in Iran, activists say
Unwinding History's Secrets: Looking for the Response to Antiquated Human advancements
Remain Fit: Powerful Wellness and Work-out Schedules for a Better You
7 Countries Where Newcomers Feel Most Welcome, and 3 Where They Often Don’t
Building a Flourishing Business: Illustrations from Business people
Scientists map of old Mars river basins for the 1st time. These could be great places to search for ancient life
5 Movies That Leaving an Imprint with Inventive Innovation
A Couple of Modest Guitars for 2024
Apollo vs. Artemis: What to know about NASA's return to the moon












